The interpretation of statistically significant findings in a carcinogenicity study is difficult, in part because of the large number of statistical tests conducted. Some scientists who believe that the false positive rates in these experiments are unreasonably large often suggest that the use of multiple control groups will provide important insight into the operational false positive rates.
Introduction
One of the most difficult issues associated with the interpretation of results from a carcinogenicity study in experimental animals is the question of biological versus statistical significance. Suppose, for example, that a statistically significant increasing trend in tumor rates is detected for one or two sites among a large number of such sites examined microscopically. Can we conclude that these are real effects or are the findings simply a chance event?
This issue relates directly to the question of false positive rates in these studies, an issue that has been discussed and debated in the statistical and toxicological literature for decades. The basic argument that the overall or experiment-wise error rate may be unreasonably high (1) follows from a simple probability calculation. If M independent statistical tests are conducted, each at the p = 0.05 level, then the probability of at least one significant finding is 1 -0.95M. For M = 10 this overall probability is 0.40 and for M = 40, the probability is 0.87. In a carcinogenicity study, where 30 sites may be examined for both males and females, there is the potential for a high false positive rate (the multiplicity problem).
The actual false positive rate in a carcinogenicity study may not be nearly as high as indicated by the above probability calculation, however. As several authors (2-4) have pointed out, most scientific decisions are not based on a single statistically significant result at the 0.05 level, and further, as noted by Haseman (4), many statistical tests, in fact, operate below their nominal levels. By studying historical tumor rates from 25 studies conducted by the National Tbxicology Program (NTP), Haseman (4) concluded that a statistical decision rule that approximated the NTP biological decision process could be formulated as follows: Declare a positive finding if the p value comparing the high dose to controls is less than 0.01 for common tumors (greater than 1% historical spontaneous rate) or if the p value is less than 0.05 for uncommon tumors. ( Haseman's calculations of false positive rates used Fisher's exact test comparing the high dose to controls. Sample sizes were 50 per group.)
The applicability of Haseman's results to a wider scope of situations depends on how typical the NTP data are. In addition, one of the critical assumptions (which is generally made when analyzing unadjusted or lifetime tumor incidence data) is that the tumor counts are binomi-ally distributed. In a typical carcinogenicity bioassay design with a single control group and treated groups at several exposure levels of a chemical [e.g., IARC (5)], the binomial assumption cannot be verified. In contrast, studies with replicate groups can be used to assess the binomial assumption. Haseman et al. (6) present results from a set of 18 color additive studies, each employing a dual control group design. In brief, they found no evidence of extrabinomial, within-study variability in these studies. They again reaffirmed, however, the idea that more stringent evidence than a single p < 0.05 for common tumors should be required for biological significance; otherwise, the experiment-wise false positive rate could be unacceptably high. Haseman (4) , tumor types with low rates have negligible false positive rates, and therefore contribute minimally to the overall (experiment-wise) false positive rate. The conditional rates calculated with group 1 as the treated group and with group 2 as the treated group are not identical because of occasional differences in denominators. Sometimes these differences in false positive rates are appreciable (Table 2 ). Such differences are due to the discrete nature of the counts used in the test and the fact that even with denominators of almost 100, the probability distributions take large jumps. Moreover, there are sometimes considerable differences between false positive rates calculated conditionally and unconditionally ( Thus, even though these data sets do not provide strong evidence of extrabinomial variation, they do reinforce the idea that false positives continue to be a substantial problem in carcinogenicity studies.
p-Value Plot as a Diagnostic Tool
As noted by a number of authors (7, 8) , considerations other than p values alone bear upon the question of carcinogenicity in a particular instance. As stated in the 1980 IARC monograph (7): "P-values are objective facts, but unless a p-value is very extreme, the proper use of it in the light of other infornation to decide whether or not the test agent really is carcinogenic involves subjective judgment." Haseman (4) argues that additional factors to be considered should include the historical control tumor rate for the tumor in question, the survival histories of the control and treated groups, dose-dependence and similarity of findings among different sexes and species, and biological plausibility in light of earlier toxicological studies, mutagenicity findings, etc.
A large part of the role of the statistician is to provide objective means for interpreting data and results to assist in making subjective judgments. In this regard, we highlight three areas in which statistical techniques may be most useful.
The first is the formal application of statistical methods, incorporating historical controls into the analysis of tumor data. Several methods are currently available (9, 10) . These methods have been found to be quite informative when tumor rates are low and the potential dose-response is low enough to be uncertain.
The second area involves the evaluation of the results in one sex (e.g., males) while taking into account the results in the other sex (females). Thus, one could treat Figure 2 , we display the resulting 1-p values with expectations and percentiles recomputed accordingly for the reduced set. Note that the test does not appear as conservative as in Figure 1 , as many of the 1-p values are now above their expectations. Of particular interest are the low p values. We can compare the three lowest values to their expectations and to the 2.5% point (envelope), as shown in Table 3 .
As can also be seen from Figure 2 , the two lowest p values are below their expected values, but are considerably above the 2.5% values from their respective distributions. (Recall that we plot 1-p's rather than p's, so that the relevant part of Figure 2 is in the upper-right corner). Figure 3 plotting procedure described. As the smallest p value from these trend tests is 0.09, there is no evidence of increasing tumor rates as a result of feeding the chemical to mice.
Our final example is from a chronic feeding study in mice with chemical 2. Figure 4 displays In an effort to shed some light on these questions, we conducted several computer simulation studies where we generated binomially distributed data (using the SAS function RANBIN), statistically analyzed them, and produced corresponding p value plots. We provide the details behind the simulations and our results in this section.
The statistical procedure used throughout was the Cochran-Armitage (CA) trend test (12, 13) . For the first set of simulations, we generated data consistent with the null hypothesis of no treatment effect. Initially 5000 independent sets were generated, each set consisting of a control and three nonzero dose groups of size 60 (doses 1, 2, 3). Of these, 1000 were generated with a spontaneous tumor rate of 2%, 2000 were generated with a rate of 5%, and the remaining 2000 were generated with a spontaneous rate of 10%. With these 5000 cases as input data to the CA test, we calculated rejection rates of the test for both a continuity-corrected and noncontinuitycorrected version. The results are shown in Table 5 .
Thus, with spontaneous rates of 10% or less, the noncontinuity corrected version of the CA test operates close to its nominal level. When tumor rates are low (i.e., 2%), the test is somewhat conservative, but not nearly as con- In particular, we examined the 25th percentile (over the 200 studies), median (over the 200 studies), and 75th percentile (over the 200 studies) of the ordered p values from the 200 studies. These were plotted along with expected values and the (2.5 to 97.5%) envelope of the p-value plot as defined earlier. Figure 5 displays the results. Notice that the median of the 200 studies matches closely with the expected values and that the 25th and 75th percentile curves both lie well within the envelope.
A second set of independent simulations was generated to represent the situation where treatment effects were present. The method of generating the data was the same as for the null case, except at two sites per study. Instead of counts generated at a constant 5% rate, counts for these two sites were generated as independent binomials with rates 0.005, 0.025, 0.075, and 0.100, respectively, in the four groups (doses 0, 1, 2, 3 We again examined the 25th percentile, median, and 75th percentiles from the ordered p values for the 200 studies. Figure 6 shows a very different pattern from the one presented in Figure 5 . Although the lower left portion of Figure 6 looks similar to Figure 5, all Results from the first simulation case with no treatment-related effects give us information on level.
Results from the second simulation case give us information on power. These are summarized in Table 6 . 
Conclusions and Discussion
From our analysis of the mouse study data with chemical 1, we see that statistically significant results can arise due to chance. These data do not, however, provide overwhelming evidence of extrabinomial variation, although such an hypothesis cannot be rejected, either. As Haseman and colleagues point out (6) , such data reinforce the idea of cautiously interpreting statistically significant results. Even the use of the more conservative decision rule based on p < 0.01 may not be conservative enough for some data sets.
We have developed and advocated the p-value plot as an aid in decision-making for carcinogenicity studies. These plots are useful diagnostic tools to informally assess the overall treatment-related effects of the experimental compound. When many statistical tests have been made, this fact is automatically incorporated. The plots easily exhibit the conservative nature of some tests (contrast, for example, Fig. 1 Figs. 5 and 6 ).
Through the use of a limited set of computer simulations, we have evaluated several decision rules. With a distribution of spontaneous tumor rates considerably higher than those from the 25 NTP studies reviewed by Haseman, and with the Cochran-Armitage trend test instead of the more conservative Fisher's test, we saw the rule using p < 0.01 had a false positive rate of 19%. In contrast, using rules constructed from p-value plots, we were able to reduce this rate to acceptable levels. Of course, this resulted in a slight loss in power to detect treatmentrelated effects.
Although it may appear that our findings are inconsistent with those of Haseman, this is not so. The historical control tumor rates reported in Haseman (4) contained many low rates. Nine of the 27 type/sites had rates less than 2% in rats and seventeen of the 27 had rates less than 2% in mice. Had these rates been higher, the overall false positive rates reported by Haseman would have been greater. Second, Haseman's analysis was based on Fisher's exact test, which is very conservative, regardless of the background rate. In contrast, we showed that the Cochran-Armitage trend test operates close to its nominal level when the spontaneous tumor rate is in the 5 to 10% range. Thus, our studies are complementary rather than contrary to those of Haseman.
Because hypothesis testing seems to be the most common statistical approach to the analysis of data from carcinogenicity studies, we believe that it is therefore most appropriate (in the spirit of the Neyman-Pearson approach to hypothesis testing) to first control the Type I error rate in these studies. By employing statistical techniques that control the overall false positive rate, such as those based on p-value plots or other methods of adjustment (11, 16, 17) , this goal can be achieved. Several such decision rules have been proposed in this paper and evaluated in the limited set of simulation studies conducted. Other such rules can easily be contemplated. Their properties can further be investigated under a variety of conditions, again with computer simulation.
The main advantage ofp-value plots is that they provide the statistician and toxicologist with a simple way to visually summarize the results of numerous statistical tests and compare the p values obtained to those that would be expected in the absence of compound-related effects. By examining the shape of the observed 1-p curve as well as its largest values, information about the overall effects of treatment may be deduced. Thus, we believe that such graphical evaluations of data may serve as a useful tool in interpreting results from carcinogenicity studies. The final decision process, however, needs to be an interdisciplinary effort with input from pathologists, toxicologists, and statisticians (8) .
